Putaminal Hyperintensity on T1-Weighted MR Imaging in Patients with the Parkinson Variant of Multiple System Atrophy

References

1. ↵
   Poewe W. Clinical features, diagnosis, and imaging of parkinsonian syndromes. Curr Opin Neurol Neurosurg 1993;6:333–38

   PubMed
2. ↵
   Litvan I, Agid Y, Jankovic J, et al. Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy. Neurology 1996;46:922–30

   Abstract/FREE Full Text
3. Hughes AJ, Daniel SE, Ben-Shlomo Y, et al. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 2002;125:861–70

   Abstract/FREE Full Text
4. ↵
   Seppi K, Schocke MF, Esterhammer R, et al. Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy. Neurology 2003;60:922–27

   Abstract/FREE Full Text
5. ↵
   Schocke MF, Seppi K, Esterhammer R, et al. Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD. Neurology 2002;58:575–80

   Abstract/FREE Full Text
6. ↵
   Kraft E, Trenkwalder C, Dorothee PA. T2*-weighted MRI differentiates multiple system atrophy from Parkinson's disease. Neurology 2002;59:1265–67

   Abstract/FREE Full Text
7. ↵
   Schrag A, Good CD, Miszkiel K, et al. Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology 2000;54:697–702

   Abstract/FREE Full Text
8. ↵
   Watanabe H, Saito Y, Terao S, et al. Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients. Brain 2002;125:1070–83

   Abstract/FREE Full Text
9. ↵
   Wenning GK, Ben-Shlomo Y, Magalhaes M, et al. Clinical features and natural history of multiple system atrophy: an analysis of 100 cases. Brain 1994;117:835–45

   Abstract/FREE Full Text
10. ↵
    Schrag A, Kingsley D, Phatouros C, et al. Clinical usefulness of magnetic resonance imaging in multiple system atrophy. J Neurol Neurosurg Psychiatry 1998;65:65–71

    Abstract/FREE Full Text
11. ↵
    Kraft E, Schwarz J, Trenkwalder C, et al. The combination of hypointense and hyperintense signal changes on T2-weighted magnetic resonance imaging sequences: a specific marker of multiple system atrophy? Arch Neurol 1999;56:225–28

    CrossRefPubMedWeb of Science
12. ↵
    Gilman S, Low PA, Quinn N, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 1999;163:94–98

    CrossRefPubMedWeb of Science
13. ↵
    Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1997;48:119–25

    Abstract/FREE Full Text
14. ↵
    Litvan I, Bhatia KP, Burn DJ, et al. Movement Disorders Society Scientific Issues Committee. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 2003;18:467–86

    CrossRefPubMedWeb of Science
15. ↵
    Ito S, Shirai W, Hattori T. Evaluating posterolateral linearization of the putaminal margin with magnetic resonance imaging to diagnose the Parkinson variant of multiple systems atrophy. Mov Disord 2007;22:578–81

    CrossRefPubMed
16. ↵
    Rockette HE, Gur D, Metz CE. The use of continuous and discrete confidence judgments in receiver operating characteristic studies of diagnostic imaging techniques. Invest Radiol 1992;27:169–72

    CrossRefPubMedWeb of Science
17. ↵
    Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159–74

    CrossRefPubMedWeb of Science
18. ↵
    Metz CE. Basic principles of ROC analysis. Semin Nucl Med 1978;8:283–98

    CrossRefPubMedWeb of Science
19. ↵
    Cakirer S, Karaarslan E, Arslan A. Spontaneously T1-hyperintense lesions of the brain on MRI: a pictorial review. Curr Probl Diagn Radiol 2003;32:194–217

    CrossRefPubMed
20. ↵
    Macia F, Yekhlef F, Ballan G, et al. T2-hyperintense lateral rim and hypointense putamen are typical but not exclusive of multiple system atrophy. Arch Neurol 2001;58:1024–26

    CrossRefPubMed
21. Bhattacharya K, Saadia D, Eisenkraft B, et al. Brain magnetic resonance imaging in multiple-system atrophy and Parkinson disease: a diagnostic algorithm. Arch Neurol 2002;59:835–42

    CrossRefPubMedWeb of Science
22. ↵
    Watanabe H, Fukatsu H, Hishikawa N, et al. Field strengths and sequences influence putaminal MRI findings in multiple system atrophy. Neurology 2004;62:671

    FREE Full Text
23. ↵
    Schwarz J, Weis S, Kraft E, et al. Signal changes on MRI and increases in reactive microgliosis, astrogliosis, and iron in the putamen of two patients with multiple system atrophy. J Neurol Neurosurg Psychiatry 1996;60:98–101

    Abstract/FREE Full Text
24. ↵
    Olanow CW. Magnetic resonance imaging in parkinsonism. Neurol Clin 1992;2:405–20
25. ↵
    Schulz JB, Skalej M, Wedekind D, et al. Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy. Ann Neurol 1999;45:65–74

    CrossRefPubMedWeb of Science
26. ↵
    Federico F, Simone IL, Lucivero V, et al. Proton magnetic resonance spectroscopy in Parkinson's disease and atypical parkinsonian disorders. Mov Disord 1997;12:903–09

    CrossRefPubMedWeb of Science